Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: Evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods

Bone Marrow Transplantation

Volumn 22, Issue 11, 1998, Pages 1065-1070

  Testoni, N ^a,b   Lemoli, R M ^a   Martinelli, G ^a   Carboni, C ^a   Pelliconi, S ^a   Ottaviani, E ^a   Ruggeri, D ^a   Rizzi, S ^a   Motta, M R ^a   Visani, G ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Institute of Hematology and Clinical Oncology 'LA Seragnoli'   (Italy)

Author keywords

AML; Cytogenetics; MDS; Molecular studies; PBSC

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKEMIA REMISSION; MALE; MOLECULAR BIOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TUMOR CELL;

EID: 0031787875     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701491     Document Type: Article

References (24)

1. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606-1614.
2. Cassileth PA, Andersen J, Lazarus HM et al. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
3. Korbling M, Fliedner TM, Holle R et al. Autologous blood stem cell (ABSCT) vs purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991; 7: 343-349.
4. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
5. Demirer T, Buckner CD, Appelbaum FR et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995; 15: 915-922.
6. Demuynck H, Delforge M, Verhoef GEG et al. Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromes. Br J Haematol 1996; 92: 351-355.
7. Laporte JP, Gorin NC, Feuchtenbaum J et al. Relapse after autografting with peripheral blood stem cells. Lancet 1987; 2: 1393.
8. Reiffers J, Korbling M, Labopin M et al. Autologous blood stem cells transplantation vs autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. Int J Cell Clon 1992; 10: 111-113.
9. Brenner MK, Rill DR, Moen RC et al. Gene marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 41: 85-86.
10. Motta MR, Mangianti S, Rizzi S et al. Pharmacological purging of minimal residual disease from peripheral blood stem cells collections of acute myeloblastic leukemia patients: preclinical studies. Exp Hematol 1997; 25: 1261-1269.
11. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
12. ISCN 1995. An International System for Human Cytogenetic Nomenclature. Mitelman F (ed). S Karger: Basel, 1995.
13. Martinelli G, Remiddi C, Visani G et al. Molecular analysis of PML-RARα fusion mRNA detected by reverse-transcription polymerase chain reaction assay in long-term disease-free acute promyelocytic leukaemia patients. Br J Haematol 1995; 90: 966-968.
14. Zaccaria A, Testoni N, Martinelli G et al. Four-chromosomes complex translocations in acute promyelocytic leukaemia. Description of two cases. Eur J Haematol 1994; 52: 129-133.
15. Liu P, Tarie SA, Hajra A et al. Fusion between transcription factor in CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041-1044,
16. Claxton DP, Liu P, Hsu HB et al. Detection of fusion between transcript generated by the inversion 16 chromosome in acute myelogenous leukemia, Blood 1994; 83: 1750-1756.
17. Guerrasio A, Rosso C, Martinelli G et al. Polyclonal hemopoiesis associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continuous clinical remission. Br J Haematol 1995; 90: 364-368.
18. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
19. Nagafuji K, Harada M, Takamatsu Y et al. Evaluation of leukemic contamination in peripheral blood stem cell harvests by reverse-transcriptase polymerase chain reaction. Br J Haematol 1993; 88: 578-583.
20. To LB, Russell J, Moore S, Juttner CA. Residual leukemia cannot be detected in very early remission peripheral blood stem cell collection in acute non-lymphoblastic leukemia. Leukemia Res 1987; 11: 327-329.
21. Carella AM, Dejana A, Lerma E et al. In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high risk MDS, secondary or therapy-related acute myelogenous leukaemia. Br J Haematol 1996; 95: 127-130.
22. White DL, Hutchins CJ, Turczynowicz S et al. Detection of minimal residual disease in an AML with trysomy 8 using interphase FISH. Pathology 1997; 29: 289-293.
23. Testoni N, Martinelli G, Zaccaria A et al. Detection of occasional and clonal aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1141-1145.
24. Meloni G, Diverio D, Vignetti M et al. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of PML-RARa fusion gene. Blood 1997; 90: 1321-1325.